Literature DB >> 28177966

High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.

Cari F Kessing1, Serena Spudich, Victor Valcour, Pearline Cartwright, Thep Chalermchai, James L K Fletcher, Hiroshi Takata, Carmen Nichols, Benjamin J Josey, Bonnie Slike, Shelly J Krebs, Napapon Sailsuta, Sukalaya Lerdlum, Linda Jagodzinski, Somporn Tipsuk, Duanghathai Suttichom, Somprartthana Rattanamanee, Henrik Zetterberg, Joanna Hellmuth, Nittaya Phanuphak, Merlin L Robb, Nelson L Michael, Jintanat Ananworanich, Lydie Trautmann.   

Abstract

BACKGROUND: Central nervous system (CNS) infiltration by CD8 T cells is associated with neuroinflammation in many neurodegenerative diseases, including HIV-associated dementia. However, the role of CD8 T cells in the CNS during acute HIV infection (AHI) is unknown.
METHODS: We analyzed the phenotype, gene expression, T cell receptor (TCR) repertoire, and HIV specificity of CD8 T cells in cerebrospinal fluid (CSF) of a unique cohort captured during the earliest stages of AHI (n = 26), chronic (n = 23), and uninfected (n = 8).
RESULTS: CSF CD8 T cells were elevated in AHI compared with uninfected controls. The frequency of activated CSF CD8 T cells positively correlated to CSF HIV RNA and to markers of CNS inflammation. In contrast, activated CSF CD8 T cells during chronic HIV infection were associated with markers of neurological injury and microglial activation. CSF CD8 T cells in AHI exhibited increased functional gene expression profiles associated with CD8 T cells effector function, proliferation, and TCR signaling, a unique restricted TCR Vbeta repertoire and contained HIV-specific CD8 T cells directed to unique HIV epitopes compared with the periphery.
CONCLUSIONS: These results suggest that CSF CD8 T cells in AHI expanding in the CNS are functional and directed against HIV antigens. These cells could thus play a beneficial role protective of injury seen in chronic HIV infection if combination antiretroviral therapy is initiated early.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28177966      PMCID: PMC5388590          DOI: 10.1097/QAI.0000000000001301

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  36 in total

1.  Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

Authors:  Hendrik Streeck; Heiko Jessen; Galit Alter; Nickolas Teigen; Mike T Waring; Arne Jessen; Ingrid Stahmer; Jan van Lunzen; Mathias Lichterfeld; Xiaojiang Gao; Todd M Allen; Mary Carrington; Bruce D Walker; Juergen K Rockstroh; Marcus Altfeld
Journal:  J Infect Dis       Date:  2006-08-15       Impact factor: 5.226

Review 2.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

3.  CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals.

Authors:  Sonia Bastidas; Frederik Graw; Miranda Z Smith; Herbert Kuster; Huldrych F Günthard; Annette Oxenius
Journal:  J Immunol       Date:  2014-01-20       Impact factor: 5.422

Review 4.  Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.

Authors:  Avi Nath
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

5.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

6.  In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

Authors:  Dafna Bonneh-Barkay; Guoji Wang; Adam Starkey; Ronald L Hamilton; Clayton A Wiley
Journal:  J Neuroinflammation       Date:  2010-06-11       Impact factor: 8.322

7.  Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.

Authors:  C Jassoy; R P Johnson; B A Navia; J Worth; B D Walker
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

Review 8.  Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

Authors:  Harald Neumann; Isabelle M Medana; Jan Bauer; Hans Lassmann
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

9.  Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects.

Authors:  Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Rebecca Basham; Laurie Lebo; Husamettin Erdem; Kirsten Haman; Malcolm Avison; Kevin Waddell; David W Haas; Spyros A Kalams
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

10.  Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid.

Authors:  Oliver M Grauer; Doris Reichelt; Ute Grüneberg; Hubertus Lohmann; Tilman Schneider-Hohendorf; Andreas Schulte-Mecklenbeck; Catharina C Gross; Sven G Meuth; Heinz Wiendl; Ingo W Husstedt
Journal:  Ann Clin Transl Neurol       Date:  2015-08-18       Impact factor: 4.511

View more
  20 in total

1.  Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?

Authors:  Peter D Burbelo; Richard W Price; Lars Hagberg; Hiroyu Hatano; Serena Spudich; Steven G Deeks; Magnus Gisslén
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

2.  Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.

Authors:  Serena Spudich; Kevin R Robertson; Ronald J Bosch; Rajesh T Gandhi; Joshua C Cyktor; Hanna Mar; Bernard J Macatangay; Christina M Lalama; Charles Rinaldo; Ann C Collier; Catherine Godfrey; Joseph J Eron; Deborah McMahon; Jana L Jacobs; Dianna Koontz; Evelyn Hogg; Alyssa Vecchio; John W Mellors
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

Review 3.  Neurological Complications of HIV Infection.

Authors:  Shelli Farhadian; Payal Patel; Serena Spudich
Journal:  Curr Infect Dis Rep       Date:  2017-11-21       Impact factor: 3.725

4.  Interferon-α-Mediated Activation of T Cells from Healthy and HIV-Infected Individuals Is Suppressed by Δ9-Tetrahydrocannabinol.

Authors:  Joseph E Henriquez; Michael D Rizzo; Robert B Crawford; Peter Gulick; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2018-07-19       Impact factor: 4.030

5.  In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.

Authors:  Cari F Kessing; Christopher C Nixon; Chuan Li; Perry Tsai; Hiroshi Takata; Guillaume Mousseau; Phong T Ho; Jenna B Honeycutt; Mohammad Fallahi; Lydie Trautmann; J Victor Garcia; Susana T Valente
Journal:  Cell Rep       Date:  2017-10-17       Impact factor: 9.423

Review 6.  Role of T Lymphocytes in HIV Neuropathogenesis.

Authors:  Caroline Subra; Lydie Trautmann
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

7.  Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.

Authors:  Ryan Sanford; Beau M Ances; Dieter J Meyerhoff; Richard W Price; Dietmar Fuchs; Henrik Zetterberg; Serena Spudich; D Louis Collins
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

8.  Δ9-Tetrahydrocannabinol (THC) Impairs CD8+ T Cell-Mediated Activation of Astrocytes.

Authors:  Joseph E Henriquez; Anthony P Bach; Karina M Matos-Fernandez; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2020-03-26       Impact factor: 4.147

9.  Distinct cellular immune properties in cerebrospinal fluid are associated with cognition in HIV-infected individuals initiating antiretroviral therapy.

Authors:  Beret Amundson; Lillin Lai; Mark J Mulligan; Yong Xu; Zidou Zheng; Suprateek Kundu; Jeffrey L Lennox; Drenna Waldrop-Valverde; Donald Franklin; Alison Swaims-Kohlmeier; Scott L Letendre; Albert M Anderson
Journal:  J Neuroimmunol       Date:  2020-04-27       Impact factor: 3.478

Review 10.  Evolution and Diversity of Immune Responses during Acute HIV Infection.

Authors:  Samuel W Kazer; Bruce D Walker; Alex K Shalek
Journal:  Immunity       Date:  2020-11-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.